Benign Prostatic Hyperplasia Clinical Trials 2023
Browse 13 Benign Prostatic Hyperplasia Medical Studies Across 33 Cities
34 Benign Prostatic Hyperplasia Clinics
Reviewed by Michael Gill, B. Sc.
10 Benign Prostatic Hyperplasia Clinical Trials Near Me
Top Hospitals for Benign Prostatic Hyperplasia Clinical Trials



University Hospitals Cleveland Medical Center
Cleveland
1Active Trials
1All Time Trials for Benign Prostatic Hyperplasia
2023First Benign Prostatic Hyperplasia Trial
UH Brainard Medical Bldg
Lyndhurst
1Active Trials
1All Time Trials for Benign Prostatic Hyperplasia
2023First Benign Prostatic Hyperplasia Trial
UH Regional Hospitals - Richmond Campus
Richmond Heights
1Active Trials
1All Time Trials for Benign Prostatic Hyperplasia
2023First Benign Prostatic Hyperplasia Trial
Thunder Bay Regional Health Sciences Centre
Thunder Bay
1Active Trials
1All Time Trials for Benign Prostatic Hyperplasia
2022First Benign Prostatic Hyperplasia Trial
Top Cities for Benign Prostatic Hyperplasia Clinical Trials
Benign Prostatic Hyperplasia Clinical Trials by Phase of TrialN/A Benign Prostatic Hyperplasia Clinical Trials
Benign Prostatic Hyperplasia Clinical Trials by Age Group7Active Benign Prostatic Hyperplasia Clinical Trials
6Number of Unique Treatments
5Number of Active Locations
18+ Benign Prostatic Hyperplasia Clinical Trials
Most Recent Benign Prostatic Hyperplasia Clinical Trials13Active Benign Prostatic Hyperplasia Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Treatment Name
Active Benign Prostatic Hyperplasia Clinical Trials
All Time Trials for Benign Prostatic Hyperplasia
First Recorded Benign Prostatic Hyperplasia Trial
Prostate Artery Embolization
2
5
2014
Treatment
2
2
2002
Intravesical Botox injection
1
1
2023
Thulium Fibre Laser
1
1
2022
SoracteLite(TM) TPLA for BPH
1
1
2020
Treatment
Year
Sponsor
Vibegron
2019
Urovant Sciences GmbH
Vibegron
2019
Urovant Sciences GmbH
About The Author
Michael Gill - B. Sc.
First Published: October 9th, 2021
Last Reviewed: September 8th, 2023
References1 Olweny EO, Jow SL, Jow WW. Prolieve Transurethral Thermodilatation for treatment of Symptomatic Benign Prostatic Hyperplasia: 5-Year Results from a Prospective Multicenter Trial. J Endourol. 2021 Nov 1. doi: 10.1089/end.2021.0240. [Epub ahead of print] https://pubmed.ncbi.nlm.nih.gov/343142412 Allameh F, Basiri A, Razzaghi M, Abedi AR, Fallah-Karkan M, Ghiasy S, Hosseininia SM, Montazeri S. Clinical Efficacy of Transurethral Resection of the Prostate Combined with Oral Anticholinergics or Botulinum Toxin - A Injection to Treat Benign Prostatic Hyperplasia with Overactive Bladder: A Case-Control Study. Clin Pharmacol. 2020 Jun 26;12:75-81. doi: 10.2147/CPAA.S256051. eCollection 2020. https://pubmed.ncbi.nlm.nih.gov/326170233 Antunes AA, Srougi M, Coelho RF, de Campos Freire G. Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Nat Clin Pract Urol. 2007 Mar;4(3):155-60. doi: 10.1038/ncpuro0735. https://pubmed.ncbi.nlm.nih.gov/173476604 Olweny EO, Jow SL, Jow WW. Prolieve Transurethral Thermodilatation for Treatment of Symptomatic Benign Prostatic Hyperplasia: 5-Year Results from a Prospective Multicenter Trial. J Endourol. 2022 Jan;36(1):117-123. doi: 10.1089/end.2021.0240. Epub 2021 Nov 1. https://pubmed.ncbi.nlm.nih.gov/343142415 Fusco F, Creta M, De Nunzio C, Iacovelli V, Mangiapia F, Li Marzi V, Finazzi Agrò E. Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans. BMC Urol. 2018 Mar 9;18(1):15. doi: 10.1186/s12894-018-0329-4. Review. https://pubmed.ncbi.nlm.nih.gov/295192366 Ahyai SA, Marik I, Ludwig TA, Becker A, Asdjodi S, Kluth L, Chun F, Fisch M, Schmid M. Super early detailed assessment of lower urinary tract symptoms after holmium laser enucleation of the prostate (HoLEP): a prospective study. World J Urol. 2020 Dec;38(12):3207-3217. doi: 10.1007/s00345-020-03126-x. Epub 2020 Feb 21. https://pubmed.ncbi.nlm.nih.gov/320865717 Rapp DE, Lucioni A, Bales GT. Botulinum toxin injection: a review of injection principles and protocols. Int Braz J Urol. 2007 Mar-Apr;33(2):132-41. doi: 10.1590/s1677-55382007000200002. https://pubmed.ncbi.nlm.nih.gov/174885318 Rapp DE, Lucioni A, Bales GT. Botulinum toxin injection: a review of injection principles and protocols. Int Braz J Urol. 2007 Mar-Apr;33(2):132-41. Review. https://pubmed.ncbi.nlm.nih.gov/174885319 Fusco F, Creta M, De Nunzio C, Iacovelli V, Mangiapia F, Li Marzi V, Finazzi Agro E. Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans. BMC Urol. 2018 Mar 9;18(1):15. doi: 10.1186/s12894-018-0329-4. https://pubmed.ncbi.nlm.nih.gov/2951923610 Antunes AA, Srougi M, Coelho RF, de Campos Freire G. Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Nat Clin Pract Urol. 2007 Mar;4(3):155-60. Review. https://pubmed.ncbi.nlm.nih.gov/17347660